Showing results (181-190 of 211) with videos related to
Sort By:
Pageof 22
Mbio|August 3, 2023
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concernRyan P McNamara, Jenny S Maron, Julie Boucau, et al.Cell Stem Cell|January 29, 2021
Dissecting ELANE neutropenia pathogenicity by human HSC gene editingShuquan Rao, Yao Yao, Josias Soares de Brito, et al.Nature Communications|May 20, 2016
ISG15 deficiency and increased viral resistance in humans but not miceScott D Speer, Zhi Li, Sofija Buta, et al.Nature Microbiology|May 4, 2023
Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirusSatoshi Ikegame, Jillian C Carmichael, Heather Wells, et al.Science Translational Medicine|June 10, 2026
A cocktail of human mAbs targeting the henipavirus fusion and receptor binding proteins provides cross-species neutralizationAxel A Guzmán-Solís, Mohamed Ouizougun-Oubari, Olivier Escaffre, et al.Nature Microbiology|October 15, 2025
The IFIT2-IFIT3 antiviral complex targets short 5' untranslated regions on viral mRNAs for translation inhibitionDustin R Glasner, Candace Todd, Brian Cook, et al.Gut Microbes|August 2, 2022
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infectionJulia A Brown, Katherine Z Sanidad, Serena Lucotti, et al.Lancet Regional Health. Americas|November 29, 2021
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, ArgentinaRossana Elena Chahla, Rodrigo Hernán Tomas-Grau, Silvia Inés Cazorla, et al.Plos Pathogens|May 3, 2013
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionFrederic Vigant, Jihye Lee, Axel Hollmann, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
A broad-spectrum antiviral targeting entry of enveloped virusesMike C Wolf, Alexander N Freiberg, Tinghu Zhang, et al.Pageof 22